Alternative clinical trial designs

被引:4
|
作者
Harvin, John A. [1 ]
Zarzaur, Ben L. [2 ]
Nirula, Raminder [3 ]
King, Benjamin T. [4 ]
Malhotra, Ajai K. [5 ]
机构
[1] Univ Texas Houston, McGovern Med Sch, Surg, Houston, TX USA
[2] Univ Wisconsin, Sch Med & Publ Hlth, Surg, Madison, WI USA
[3] Univ Utah, Sch Med, Surg, Salt Lake City, UT USA
[4] Univ Texas Austin, Dell Med Sch, Neurol, Austin, TX 78712 USA
[5] Univ Vermont, Med Ctr, Surg, Burlington, VT 05401 USA
关键词
SPLENIC INJURY; TRAUMA; PLASMA; EMBOLIZATION; MULTICENTER; MANAGEMENT; RATIONALE; MORTALITY;
D O I
10.1136/tsaco-2019-000420
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
High-quality clinical trials are needed to advance the care of injured patients. Traditional randomized clinical trials in trauma have challenges in generating new knowledge due to many issues, including logistical difficulties performing individual randomization, unclear pretrial estimates of treatment effect leading to often unpowered studies, and difficulty assessing the generalizability of an intervention given the heterogeneity of both patients and trauma centers. In this review, we discuss alternative clinical trial designs that can address some of these difficulties. These include pragmatic trials, cluster randomization, cluster randomized stepped wedge designs, factorial trials, and adaptive designs. Additionally, we discuss how Bayesian methods of inference may provide more knowledge to trauma and acute care surgeons compared with traditional, frequentist methods.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] CLINICAL TRIAL DESIGNS WITH REAL WORLD ENDPOINTS
    Margolis, D. J.
    WOUND REPAIR AND REGENERATION, 2015, 23 (04) : A19 - A19
  • [32] Biomarker-adaptive clinical trial designs
    Freidlin, Boris
    Korn, Edward L.
    PHARMACOGENOMICS, 2010, 11 (12) : 1679 - 1682
  • [33] Advancing Effective Clinical Trial Designs for Myelofibrosis
    Kosiorek, Heidi E.
    Dueck, Amylou C.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (02) : 431 - 444
  • [34] The science (or art?) of new clinical trial designs
    Wyllie, MG
    BJU INTERNATIONAL, 2004, 94 (04) : 669 - 670
  • [35] Clinical trial designs incorporating predictive biomarkers
    Renfro, Lindsay A.
    Mallick, Himel
    An, Ming-Wen
    Sargent, Daniel J.
    Mandrekar, Sumithra J.
    CANCER TREATMENT REVIEWS, 2016, 43 : 74 - 82
  • [36] Clinical Trial Designs in Juvenile Idiopathic Arthritis
    Jennifer J. Lee
    Brian M. Feldman
    Current Treatment Options in Rheumatology, 2017, 3 (2) : 112 - 128
  • [37] Statistical trial designs and clinical practice: Are they compatible?
    Punt, CJA
    ONKOLOGIE, 2003, 26 (06): : 518 - 519
  • [38] Incorporating Patient Preferences into Clinical Trial Designs
    Gwinn, Katrina
    ANNALS OF NEUROLOGY, 2018, 84 : S199 - S200
  • [39] STUDY DESIGNS FOR CLINICAL TRIAL USING BIOMARKER
    Yamamoto, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 72 - 72
  • [40] Multiple comparisons in complex clinical trial designs
    Hung, H. M. James
    Wang, Sue-Jane
    BIOMETRICAL JOURNAL, 2013, 55 (03) : 420 - 429